Antifungal agents
1
 Fungus includes yeast, mold and mushrooms
 Some species are parasitic in nature
 Mycosis – diseases caused by fungus
 Common not only as primary disease but also due to:
• Widespread use of broad-spectrum antibiotics
• The use of immunosuppressant or cancer chemotherapy
• The spread of AIDS
Fungal infections: systemic or superficial
Antifungal agents…
2
Systemic antifungal agents
 Amphotericin B
 Flucytosine
 Azoles
• Imidazoles: Ketoconazole
• Traizoles: Itraconazole, fluconazole and voriconazole
 Griseofulvin, Terbinafine
– AKA systemic antifungals for mucocutaneous infections
Antifungal agents…
3
Topical antifungal agents
 Imidazoles: clotrimazole, miconazole, ketoconazole
 Nystatin, amphotericin B
 Benzoic acid and salicylic Acid
• An ointment containing benzoic and salicylic acids is
known as Whitfield's ointment
• Combines the fungistatic action of benzoate with the
keratolytic action of salicylate
• It contains benzoic acid and salicylic acid in a ratio of
2:1 (usually 6% to 3%) and is used mainly in the
treatment of Tinea pedis
4
Amphotericin B
 Polyene macrolide antibiotic
 Insoluble in water but has special formulations for iv infusion
 Has very broad spectrum antifungal activity
 Mechanism of action
• Bind to ergosterols in cell membrane lining
• Allow K+ & Mg2+ to leak out
• Cell death
Amphotericin B…
5
Pharmacokinetics
 Poorly absorbed from GIT, given orally only if there is
fungal infection of GIT
 For systemic infection, it is given by slow IV infusion
 Can also be given topically
 Poorly crosses BBB but increase passage during
inflammation
• Amph. B is used with flucytosine to treat
Cryptococcal meningitis
Amphotericin B…
6
Therapeutic use
 Meningitis caused by Coccidioides (IV/intrathecal infusion )
 Intravenous administration of amphotericin B is the DOC
• Initial treatment of cryptococcal meningitis
• Mucormycosis , severe or rapidly progressing
histoplasmosis, blastomycosis, coccidioidomycosis
• Pts not responding to azole therapy of invasive
aspergillosis, extracutaneous sporotrichosis,
trichosporonosis and other fungal sepsis
Amphotericin B…
7
Therapeutic use…
 Mycotic corneal ulcers and keratitis (topical drops or
direct subconjunctival injection)
 Fungal arthritis (local injection directly into the joint)
Amphotericin B…
8
Untoward effects
 Amph. B has low TI
 Infusion related
• Fever, chills, hypotension ( acute reactions)
• Can be decreased by
 Slowing the infusion or decreasing the daily dose
 Premed. with antipyretics, antihistamines, glucoco’ids, meperidine
 Nephrotoxicity – the commonest and serious
Hypokalemia→1/3 of pts require KCl on prplonged therapy
 Renal tubular acidosis, magnesium loss, azotemia
 Headache, N, V, malaise, weight loss, and phlebitis(Comm.)
 Anaemia, thrombocytopenia or mild leukopenia (rare)
9
Flucytosine (5-fluorocytosine)
Has antifungal activity against Cryptococcal neoformans,
Candida species and chromoblastomycosis
 Mechanism of action
• First metabolized in fungal cells to 5-fluorouracil
• Then to 5-fluorodeoxyuridine monophosphate and
fluorouridine triphosphate
 Inhibit DNA and RNA synthesis
Mammalian cells can't convert flucytosine to 5-fluorouracil
10
Flucytosine…
Pharmacokinetics
• Absorbed well and rapidly after oral administration
• Widely distributed in the body including CSF
• 80%excreted unchanged in urine
• Dose adjustment is necessary in renal dysfunction
Flucytocine…
11
Therapeutic use
• Usually used in combination with amphotericin B in treatment
of cryptococcal meningitis
Untoward effects
• Bone marrow suppression (most common)
• Rash, nausea, vomiting, diarrhea and severe enterocolitis
• Toxicity is more frequent in AIDs patients, in renal failure and
in high dose
12
Imidazoles andTriazoles
 Both classes have the same MOA and similar antifungal
spectrum
 Triazoles have less effect on human sterol synthesis
Imidazoles Triazoles
Clotrimazole Itraconazole
Ketoconazole Fluconazole
Miconazole Voriconazole
Imidazoles andTriazoles…
13
 Synthetic fungistatic agents with a broad spectrum of activity
• Many Candida species, Cryptococcus neoformans,
blastomycosis, coccidioidomycosis, histoplasmosis,
dermatophytes
• Aspergillus infection :Itraconazole and voriconazole
• Candida krusei and the agents of mucormycosis are resistant
 All azoles are contraindicated during pregnancy
Imidazoles andTriazoles…
14
Mechanism of action
• Inhibit 14--sterol demethylase, a microsomal CYP450
enzyme
• Impairs the biosynthesis of ergosterol for cytoplasmic
membrane
Methylsterols may disrupt the close packing of acyl
chains of phospholipids
Impair the functions of certain membrane-bound
enzyme such as ATPase and enzymes of the electron
transport system
Inhibit growth of the fungi
Imidazoles andTriazoles…
15
 Ketoconazole
 Has greater propensity to inhibit mammalian CYP450
enzymes
 Non-selective to fungal enzymes
 Given orally to treat systemic fungal infections
 Need acidic media for absorption
 It is toxic (low TI) and relapse is common
 Synergy with flucytosine against candida, but antagonizes
Amph.B
Imidazoles andTriazoles…
16
Ketoconazole…
Therapeutic uses
• Has been replaced by itraconazole for treatment of all
mycosis
ADRs:
• GI distress
• Endocrine effects: gynaecomastia, decreased libido,
impotence and menstrual irregularities
 Inhibition of androgen and adrenal steroid synthesis
• Hepatic dysfunction (serious)
Imidazoles andTriazoles…
17
Itraconazole
 Available in oral and IV formulation
 Absorption is increased by food and low gastric PH
 Inhibit hepatic microsomal enzymes to a lesser degree than
ketoconazole
 It does not affect mammalian steroid synthesis
 Like ketoconazole, penetrates to CSF poorly
Imidazoles andTriazoles…
18
Itraconazole…
Therapeutic use
• Blastomycosis, histoplasmosis, and sporothrix(azole of
choice )
• Aspergillosis (azoles DOC- voriconazole)
• Dermatophytoses and onychomycosis (used extensively)
Adverse effects
• Nausea and vomiting
• Rash, hypokalemia, hypertriglyceridemia
• hepatotoxicity
Imidazoles andTriazoles…
19
 Fluconazole
• Distinguished from the other azoles by its high oral
bioavi. and good CSF penetration
• Lack of the endocrine side effects of ketoconazole
• Has the least effect of all azoles on hepatic microzomal
enzm.
• It has the widest therapeutic index of azoles,
permitting more aggressive dosing in variety of fungal
infections
Imidazoles andTriazoles…
20
 Fluconazole…
 Therapeutic uses
• Azole of choice for the treatment and secondary
prophylaxis of Cryptococcal meningitis
• Candidemia
• Coccidioidomycosis
• The most commonly used agent for mucocutaneous
candidiasis
•Prophylactically used to reduce fungal infection in bone
marrow transplant recipients and AIDS patients
Imidazoles andTriazoles…
21
 Voriconazole
• Available in intravenous and oral formulation
• Well absorbed orally, with bioavailability of >90%
• Similar to itraconazole in its spectrum of action
Excellent activity against candida species including
fluconazole resistant C. krusei
Less toxic and probably more effective than
amphotericin b in the treatment of invasive aspergillosis
ADRs: rash, elevated hepatic enzyme; visual disturbances
(blurring, change in color vision or brightness; resolve with
in 30 minutes of adm.)
Echinocandins
22
• Caspofungin, micafungin, anidulafungin
• They are large cyclic peptides linked to a long-chain fatty acid
• Available only for intravenous administration
• Active against candida and aspergillus, but not C. neoformans
• Water soluble and Highly protein bound drugs
• Plasma half life: caspofungin(9-11 hrs), micafungin(11-15hrs) ,
anidulafungin (24-48 hrs)
ADRs: phlebitis at the infusion site; Histamine-like effects with
rapid infusions
Imidazoles andTriazoles…
23
Topical imidazoles
 Clotrimazole, miconazole, ketoconazole
Clinical indication
• Dermatophytic infec. Including T.corporis, T. pedis
,T.cruris, and T.versicolor (creams)
• Mucocutaneous candidiasis
• Oral thrush (oral clotrimazole lozenge)
24
 Griseofulvin
 A narrow-spectrum antifungal agent; fungistatic
 It is a potent inducer of CYP450 enzyme, fatty food  its
absorption
 Mechanism of action
•Binding to fungal microtubules to disrupt the mitotic
spindle →inhibit mitosis
 Therapeutic uses
• Only used for the treatment of dermatophytosis (orally
adm.)
Trichophyton, Microsporum and Epidermophyton
•It has largely been superseded by other drugs
(itraconazole and terbinafine)
25
 Griseofulvin…
Adverse drug reactions
 Allergic reactions- rashes, fever, serum sickness
 GI upsets, headache
 Photosensitivity
 Hepatotoxicity
 The drug should not be given to pregnant women
26
 Terbinafine
 Used for the treatment of dermatophytoses, especially
onychomycosis, Tinea cruris, Tinea corporis
 Highly lipophilic, keratinophilic fungicidal
 Mechanism of action
• Interferes with ergosterol biosynthesis, it inhibits the
fungal enzyme squalene epoxidase → accumulation of
the sterol squalene, which is toxic to the fungus
More effective than griseofulvin and itraconazole
 ADRs: GI upset, headache, or rash
27
 Nystatin
Polyene macrolide antibiotic
Mechanism of action similar to amphotericin B
Not absorbed from GI, skin or vagina
Useful only for Candida infection
Preparation are available for cutaneous, vaginal or oral
administration
• Powder, ointment and cream preparation
Hyper keratinized or crusted skin lesions do not respond
Adverse effect is uncommon
28
Topical allylamines
 Terbinafine and naftifine
Available as creams
Effective for treatment of tinea cruris and tinea corporis

Antifungal agents Africa college pre.pdf

  • 1.
    Antifungal agents 1  Fungusincludes yeast, mold and mushrooms  Some species are parasitic in nature  Mycosis – diseases caused by fungus  Common not only as primary disease but also due to: • Widespread use of broad-spectrum antibiotics • The use of immunosuppressant or cancer chemotherapy • The spread of AIDS Fungal infections: systemic or superficial
  • 2.
    Antifungal agents… 2 Systemic antifungalagents  Amphotericin B  Flucytosine  Azoles • Imidazoles: Ketoconazole • Traizoles: Itraconazole, fluconazole and voriconazole  Griseofulvin, Terbinafine – AKA systemic antifungals for mucocutaneous infections
  • 3.
    Antifungal agents… 3 Topical antifungalagents  Imidazoles: clotrimazole, miconazole, ketoconazole  Nystatin, amphotericin B  Benzoic acid and salicylic Acid • An ointment containing benzoic and salicylic acids is known as Whitfield's ointment • Combines the fungistatic action of benzoate with the keratolytic action of salicylate • It contains benzoic acid and salicylic acid in a ratio of 2:1 (usually 6% to 3%) and is used mainly in the treatment of Tinea pedis
  • 4.
    4 Amphotericin B  Polyenemacrolide antibiotic  Insoluble in water but has special formulations for iv infusion  Has very broad spectrum antifungal activity  Mechanism of action • Bind to ergosterols in cell membrane lining • Allow K+ & Mg2+ to leak out • Cell death
  • 5.
    Amphotericin B… 5 Pharmacokinetics  Poorlyabsorbed from GIT, given orally only if there is fungal infection of GIT  For systemic infection, it is given by slow IV infusion  Can also be given topically  Poorly crosses BBB but increase passage during inflammation • Amph. B is used with flucytosine to treat Cryptococcal meningitis
  • 6.
    Amphotericin B… 6 Therapeutic use Meningitis caused by Coccidioides (IV/intrathecal infusion )  Intravenous administration of amphotericin B is the DOC • Initial treatment of cryptococcal meningitis • Mucormycosis , severe or rapidly progressing histoplasmosis, blastomycosis, coccidioidomycosis • Pts not responding to azole therapy of invasive aspergillosis, extracutaneous sporotrichosis, trichosporonosis and other fungal sepsis
  • 7.
    Amphotericin B… 7 Therapeutic use… Mycotic corneal ulcers and keratitis (topical drops or direct subconjunctival injection)  Fungal arthritis (local injection directly into the joint)
  • 8.
    Amphotericin B… 8 Untoward effects Amph. B has low TI  Infusion related • Fever, chills, hypotension ( acute reactions) • Can be decreased by  Slowing the infusion or decreasing the daily dose  Premed. with antipyretics, antihistamines, glucoco’ids, meperidine  Nephrotoxicity – the commonest and serious Hypokalemia→1/3 of pts require KCl on prplonged therapy  Renal tubular acidosis, magnesium loss, azotemia  Headache, N, V, malaise, weight loss, and phlebitis(Comm.)  Anaemia, thrombocytopenia or mild leukopenia (rare)
  • 9.
    9 Flucytosine (5-fluorocytosine) Has antifungalactivity against Cryptococcal neoformans, Candida species and chromoblastomycosis  Mechanism of action • First metabolized in fungal cells to 5-fluorouracil • Then to 5-fluorodeoxyuridine monophosphate and fluorouridine triphosphate  Inhibit DNA and RNA synthesis Mammalian cells can't convert flucytosine to 5-fluorouracil
  • 10.
    10 Flucytosine… Pharmacokinetics • Absorbed welland rapidly after oral administration • Widely distributed in the body including CSF • 80%excreted unchanged in urine • Dose adjustment is necessary in renal dysfunction
  • 11.
    Flucytocine… 11 Therapeutic use • Usuallyused in combination with amphotericin B in treatment of cryptococcal meningitis Untoward effects • Bone marrow suppression (most common) • Rash, nausea, vomiting, diarrhea and severe enterocolitis • Toxicity is more frequent in AIDs patients, in renal failure and in high dose
  • 12.
    12 Imidazoles andTriazoles  Bothclasses have the same MOA and similar antifungal spectrum  Triazoles have less effect on human sterol synthesis Imidazoles Triazoles Clotrimazole Itraconazole Ketoconazole Fluconazole Miconazole Voriconazole
  • 13.
    Imidazoles andTriazoles… 13  Syntheticfungistatic agents with a broad spectrum of activity • Many Candida species, Cryptococcus neoformans, blastomycosis, coccidioidomycosis, histoplasmosis, dermatophytes • Aspergillus infection :Itraconazole and voriconazole • Candida krusei and the agents of mucormycosis are resistant  All azoles are contraindicated during pregnancy
  • 14.
    Imidazoles andTriazoles… 14 Mechanism ofaction • Inhibit 14--sterol demethylase, a microsomal CYP450 enzyme • Impairs the biosynthesis of ergosterol for cytoplasmic membrane Methylsterols may disrupt the close packing of acyl chains of phospholipids Impair the functions of certain membrane-bound enzyme such as ATPase and enzymes of the electron transport system Inhibit growth of the fungi
  • 15.
    Imidazoles andTriazoles… 15  Ketoconazole Has greater propensity to inhibit mammalian CYP450 enzymes  Non-selective to fungal enzymes  Given orally to treat systemic fungal infections  Need acidic media for absorption  It is toxic (low TI) and relapse is common  Synergy with flucytosine against candida, but antagonizes Amph.B
  • 16.
    Imidazoles andTriazoles… 16 Ketoconazole… Therapeutic uses •Has been replaced by itraconazole for treatment of all mycosis ADRs: • GI distress • Endocrine effects: gynaecomastia, decreased libido, impotence and menstrual irregularities  Inhibition of androgen and adrenal steroid synthesis • Hepatic dysfunction (serious)
  • 17.
    Imidazoles andTriazoles… 17 Itraconazole  Availablein oral and IV formulation  Absorption is increased by food and low gastric PH  Inhibit hepatic microsomal enzymes to a lesser degree than ketoconazole  It does not affect mammalian steroid synthesis  Like ketoconazole, penetrates to CSF poorly
  • 18.
    Imidazoles andTriazoles… 18 Itraconazole… Therapeutic use •Blastomycosis, histoplasmosis, and sporothrix(azole of choice ) • Aspergillosis (azoles DOC- voriconazole) • Dermatophytoses and onychomycosis (used extensively) Adverse effects • Nausea and vomiting • Rash, hypokalemia, hypertriglyceridemia • hepatotoxicity
  • 19.
    Imidazoles andTriazoles… 19  Fluconazole •Distinguished from the other azoles by its high oral bioavi. and good CSF penetration • Lack of the endocrine side effects of ketoconazole • Has the least effect of all azoles on hepatic microzomal enzm. • It has the widest therapeutic index of azoles, permitting more aggressive dosing in variety of fungal infections
  • 20.
    Imidazoles andTriazoles… 20  Fluconazole… Therapeutic uses • Azole of choice for the treatment and secondary prophylaxis of Cryptococcal meningitis • Candidemia • Coccidioidomycosis • The most commonly used agent for mucocutaneous candidiasis •Prophylactically used to reduce fungal infection in bone marrow transplant recipients and AIDS patients
  • 21.
    Imidazoles andTriazoles… 21  Voriconazole •Available in intravenous and oral formulation • Well absorbed orally, with bioavailability of >90% • Similar to itraconazole in its spectrum of action Excellent activity against candida species including fluconazole resistant C. krusei Less toxic and probably more effective than amphotericin b in the treatment of invasive aspergillosis ADRs: rash, elevated hepatic enzyme; visual disturbances (blurring, change in color vision or brightness; resolve with in 30 minutes of adm.)
  • 22.
    Echinocandins 22 • Caspofungin, micafungin,anidulafungin • They are large cyclic peptides linked to a long-chain fatty acid • Available only for intravenous administration • Active against candida and aspergillus, but not C. neoformans • Water soluble and Highly protein bound drugs • Plasma half life: caspofungin(9-11 hrs), micafungin(11-15hrs) , anidulafungin (24-48 hrs) ADRs: phlebitis at the infusion site; Histamine-like effects with rapid infusions
  • 23.
    Imidazoles andTriazoles… 23 Topical imidazoles Clotrimazole, miconazole, ketoconazole Clinical indication • Dermatophytic infec. Including T.corporis, T. pedis ,T.cruris, and T.versicolor (creams) • Mucocutaneous candidiasis • Oral thrush (oral clotrimazole lozenge)
  • 24.
    24  Griseofulvin  Anarrow-spectrum antifungal agent; fungistatic  It is a potent inducer of CYP450 enzyme, fatty food  its absorption  Mechanism of action •Binding to fungal microtubules to disrupt the mitotic spindle →inhibit mitosis  Therapeutic uses • Only used for the treatment of dermatophytosis (orally adm.) Trichophyton, Microsporum and Epidermophyton •It has largely been superseded by other drugs (itraconazole and terbinafine)
  • 25.
    25  Griseofulvin… Adverse drugreactions  Allergic reactions- rashes, fever, serum sickness  GI upsets, headache  Photosensitivity  Hepatotoxicity  The drug should not be given to pregnant women
  • 26.
    26  Terbinafine  Usedfor the treatment of dermatophytoses, especially onychomycosis, Tinea cruris, Tinea corporis  Highly lipophilic, keratinophilic fungicidal  Mechanism of action • Interferes with ergosterol biosynthesis, it inhibits the fungal enzyme squalene epoxidase → accumulation of the sterol squalene, which is toxic to the fungus More effective than griseofulvin and itraconazole  ADRs: GI upset, headache, or rash
  • 27.
    27  Nystatin Polyene macrolideantibiotic Mechanism of action similar to amphotericin B Not absorbed from GI, skin or vagina Useful only for Candida infection Preparation are available for cutaneous, vaginal or oral administration • Powder, ointment and cream preparation Hyper keratinized or crusted skin lesions do not respond Adverse effect is uncommon
  • 28.
    28 Topical allylamines  Terbinafineand naftifine Available as creams Effective for treatment of tinea cruris and tinea corporis